O. Fogel

437 total citations
21 papers, 267 citations indexed

About

O. Fogel is a scholar working on Rheumatology, Hematology and Physiology. According to data from OpenAlex, O. Fogel has authored 21 papers receiving a total of 267 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Rheumatology, 5 papers in Hematology and 5 papers in Physiology. Recurrent topics in O. Fogel's work include Autoimmune and Inflammatory Disorders Research (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). O. Fogel is often cited by papers focused on Autoimmune and Inflammatory Disorders Research (5 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). O. Fogel collaborates with scholars based in France, United States and Denmark. O. Fogel's co-authors include Jörg Tost, Gaëtane Nocturne, Corinne Miceli‐Richard, Véronique Le Guern, Saida Boudaoud, Raphaèle Séror, Xavier Mariette, C. Larroche, Rakiba Belkhir and Alain Saraux and has published in prestigious journals such as Journal of Allergy and Clinical Immunology, Annals of the Rheumatic Diseases and Lara D. Veeken.

In The Last Decade

O. Fogel

20 papers receiving 267 citations

Peers

Countries citing papers authored by O. Fogel

Since Specialization

Citations

This map shows the geographic impact of O. Fogel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by O. Fogel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites O. Fogel more than expected).

Fields of papers citing papers by O. Fogel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by O. Fogel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by O. Fogel. The network helps show where O. Fogel may publish in the future.

Co-authorship network of co-authors of O. Fogel

This figure shows the co-authorship network connecting the top 25 collaborators of O. Fogel. A scholar is included among the top collaborators of O. Fogel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with O. Fogel. O. Fogel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Title	Journal	Authors	Indexed citations
1	Real-world assessment of the efficacy and tolerability profile of JAK inhibitors in difficult-to-treat rheumatoid arthritis	Seminars in Arthritis and Rheumatism	M. Thomas, Anna Moltó et al.	1
2	T cells in the pathogenesis of axial spondyloarthritis	Joint Bone Spine	O. Fogel, Lars Rogge et al.	4
3	Recommendations for assessing the risk of cardiovascular disease and venous thromboembolism before the initiation of targeted therapies for chronic inflammatory rheumatic diseases	Joint Bone Spine	Jérôme Avouac, O. Fogel et al.	10
4	Evaluation of Patients With Rheumatoid Arthritis in Teleconsultation During the First Wave of the COVID-19 Pandemic	The Journal of Rheumatology	Jérôme Avouac, Anna Moltó et al.	5
5	Increased antibody response after SARS-CoV-2 mRNA-based vaccination in rituximab-treated patients with previous COVID-19 infection	Lara D. Veeken	Jérôme Avouac, M. Thomas et al.	1
6	Actualisation 2022 des recommandations de la Société française de rhumatologie (SFR) pour la prise en charge en pratique courante des malades atteints de spondyloarthrite, incluant le rhumatisme psoriasique	Revue du Rhumatisme	Daniel Wendling, O. Fogel et al.	3
7	Challenging diagnosis of renal failure associated with severe neurological symptoms in a patient with mixed connective tissue disease	Journal of Scleroderma and Related Disorders	O. Fogel, Idris Boudhabhay et al.	0
8	Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patients	Lara D. Veeken	Jérôme Avouac, Corinne Miceli‐Richard et al.	23
9	Passage du tocilizumab ou de l’abatacept de la forme intraveineuse vers la voie sous-cutanée pendant la pandémie de COVID-19 : expérience française	Revue du Rhumatisme	C. Frantz, Elise Descamps et al.	1
10	Systematic assessment of the humoral response against SARS-CoV-2 in a French cohort of 283 patients with rheumatic diseases	Joint Bone Spine	Jean–François Méritet, Emma André et al.	1
11	Development of Enthesopathies and Joint Structural Damage in a Murine Model of X-Linked Hypophosphatemia	Frontiers in Cell and Developmental Biology	Benjamin Salmon, O. Fogel et al.	12
12	Étude prospective de séroprévalence du Sars-Cov-2 chez 249 patients suivis pour un rhumatisme inflammatoire chronique	Revue du Rhumatisme	O. Fogel, Jean–François Méritet et al.	2
13	Internat de rhumatologie en France : évaluation de l’ancien système et inconnues de la R3C	Revue du Rhumatisme	O. Fogel, Samuel Bitoun	1
14	Deregulation of microRNA expression in monocytes and CD4+ T lymphocytes from patients with axial spondyloarthritis	Arthritis Research & Therapy	O. Fogel, Maud Fagny et al.	24
15	Early‐onset granulomatous arthritis, uveitis and skin rash: characterization of skin involvement in Blau syndrome	Journal of the European Academy of Dermatology and Venereology	O. Fogel, C. Pajot et al.	22
16	Role of the IL-12/IL-35 balance in patients with Sjögren syndrome	Journal of Allergy and Clinical Immunology	O. Fogel, Élodie Rivière et al.	35
17	THU0225 Role of the IL-12/IL-35 balance in SJÖGREN'S syndrome	Annals of the Rheumatic Diseases	O. Fogel, Élodie Rivière et al.	1
18	OP0062 Assessment of biotherapies' efficacy in blau syndrome: data from an international retrospective cohort of 23 cases	Annals of the Rheumatic Diseases	O. Fogel, A. Cantagrel et al.	1
19	Epigenetic Changes in Chronic Inflammatory Diseases	Advances in protein chemistry and structural biology	O. Fogel, Jörg Tost et al.	46
20	CXCL13 and CCL11 Serum Levels and Lymphoma and Disease Activity in Primary Sjögren's Syndrome	Arthritis & Rheumatology	Gaëtane Nocturne, Raphaèle Séror et al.	71

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact